MedTrace Logo

Qatar Universal Diabetes Outcomes (QUDOS) Study

NCT02660476 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 475

Last updated 2023-06-22

No results posted yet for this study

Summary

QUDOS is a cross-sectional population study aiming to answer key questions about diabetes and its complications in Qatar as well as identify factors associated with the development and progression of diabetes complications.

Conditions

Sponsors & Collaborators

  • Hamad Medical Corporation

    collaborator INDUSTRY

  • Weill Cornell Medical College in Qatar

    lead OTHER

Principal Investigators

  • Shahrad Taheri, PhD · Weill Cornell Medical College in Qatar

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2023-06-01
Completion
2023-06-01

Countries

  • Qatar

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02660476 on ClinicalTrials.gov